About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
S
FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Pancreatic Cancer: What You Need to Know
By
Shubham Pant
4 Videos
0 views
February 27, 2024
Comments
0
Login to view comments.
Click here to Login
Featured Video
10:25
Exelixis
Explore the mechanism of Action of a TKI in HCC
Feat.
W. Keiser
Featured Video
15:07
Exelixis
Safety and Efficacy Data of a TKI Monotherapy in HCC
Feat.
J. Mizrahi
Recommended
AUTOPLAY
ON
Related
Newest
09:01
Integrity CE
Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …
Feat.
L. Zheng
12:50
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-…
Feat.
E. Dotan
27:37
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates
Feat.
N. Uboha,
A. Turk,
K. Spencer,
M. Cecchini
08:34
Yale Cancer Center
NORPACT-1 Trial Updates: Neoadjuvant FOLFIRINOX vs. Upfront Surgery …
Feat.
J. Lacy
23:58
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Key Studies
Feat.
R. Kim,
R. Mehta
20:07
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…
Feat.
Y. Janjigian,
S. Cytryn,
S. Maron
31:40
Horizon CME
Updates in Perioperative Therapy of Pancreatic Cancer
Feat.
P. Philip
07:42
Integrity CE
Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …
Feat.
W. Burns
03:50
UCLA Health
Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…
Feat.
Z. Wainberg
12:08
Yale Cancer Center
GI Oncology Year in Review: Precision Medicine Update in Metastatic …
Feat.
J. Lacy
07:37
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "EXPEL-PANC - A Ph2 Study of BXCL701 + Pem…
Feat.
B. Weinberg
04:25
ecancer
ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRI…
Feat.
J. Knox
08:08
Integrity CE
Updates in Nonmetastatic Upper-GI Adenocarcinoma
Feat.
J. Hernandez
10:53
Yale Cancer Center
GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …
Feat.
J. Lacy
07:53
Total Health
Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia
Feat.
D. Lin
39:04
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Localized Pancreatic Cancer Controversial Cases: Panel Discussion
Feat.
M. Katz,
A. De Jesus-Acosta,
N. Zaidi,
J. He,
A. Narang,
T. Bekaii-Saab
25:56
OncoAlert
Year in Review: Pancreatic Cancers
Feat.
M. Lewis
30:55
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Medical Oncology Updates in Pancreas Cancer
Feat.
T. Bekaii-Saab
22:10
Yale Cancer Center
Pancreatic Cancer Updates From Yale Cancer Center
Feat.
J. Lacy
12:27
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreat…
Feat.
J. Knox
